Log In
BCIQ
Print this Print this
 

azilsartan/amlodipine besylate (Zacras)

  Manage Alerts
Collapse Summary General Information
Company Takeda Pharmaceutical Co. Ltd.
DescriptionFixed-dose combination of Azilva azilsartan, a once-daily angiotensin II type 1 (AT1) receptor (AGTR1) antagonist, and amlodipine besylate
Molecular Target Angiotensin II type 1 (AT1) receptor (AGTR1)
Mechanism of ActionAngiotensin II type 1 (AT1) receptor antagonist
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentMarketed
Standard IndicationHypertension
Indication DetailsTreat hypertension
Regulatory Designation Japan - Standard Review (Treat hypertension)
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today